Postdoctoral FellowBrigham and Women’s Hosp, Harvard Med. Sch., United States
Disclosure information not submitted.
Integrated multiomics profiling reveals MS-specific molecular signatures linked to progression and response to nasal anti-CD3 (Foralumab) therapy
Wednesday, April 15, 20263:45 PM - 4:00 PM US ET